- Research article
- Open Access
- Open Peer Review
Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey
© Pérez-Ríos et al; licensee BioMed Central Ltd. 2009
- Received: 11 May 2009
- Accepted: 30 December 2009
- Published: 30 December 2009
The Fagerström Test for Nicotine Dependence (FTND) is used for assessing nicotine dependence. A shorter test derived from the FTND used for the general population is the Heavy Smoking Index (HSI) (six questions vs. two). The objective of this study is to compare the validity of the HSI versus the FTND.
A survey of tobacco use in the general population was carried out in the northern Spanish region of Galicia using both the FTND and the HSI to study a representative sample of 1655 daily smokers. The HSI was compared with the FTND, considered the gold standard. Measures of sensitivity, specificity and predictive values were calculated. Concordance between the tests was also established (Cohen's kappa).
Cohen's kappa showed good agreement between measures (Kappa = 0.7); specificity values were also high (Sp = 96.2%). Sensitivity analysis in females (Se = 62.3%) did not show good agreement.
The HSI can be used as a reasonably good screening test in order to identify daily smokers with high nicotine dependence. Nevertheless, for populations or subpopulations having low nicotine dependence, such as women, the FTND is more reliable.
- Nicotine Dependence
- Tobacco Consumption
- Daily Smoker
- General Population Survey
- High Nicotine Dependence
Cross-sectional studies, especially those focused on tobacco use, generally employ long and overloaded questionnaires. The assessment of nicotine dependence is one of the main objectives addressed in tobacco studies. Hence, the availability of brief and reliable self-reported measures of addiction for epidemiological studies would be highly desirable. Several instruments have been developed to assess nicotine tobacco dependence. One of them is the Fagerström Test for Nicotine Dependence (FTND), a non invasive and easy-to-obtain self report tool that conceptualizes dependence through physiological and behavioral symptoms. The current version includes six items  and though the test is brief, its completion requires a few minutes. Therefore a time saving test was developed, the Heavy Smoking Index (HSI) derived from the FTND . This test includes only 2 items from the FTND and can also be used to estimate the degree of dependence.
The HSI's usefulness in assessing nicotine dependence in general population surveys aimed at health planning has not yet been completely established. Furthermore, most studies have not examined the measures of validity of HSI versus FTND test by gender in general population. The main goal of the present study was to estimate the agreement between the HSI compared with the FTND in a representative population sample with special attention to gender differences.
A survey of tobacco use in the general population was carried out in Galicia (Spain) between December 2004 and January 2005. Galicia is located in northwest Spain; in 2004 it had a population of 2.7 million and a prevalence of tobacco consumption of 25%. The sampled population was taken from the Galician GP patients database (Tarxeta Sanitaria), which accounts for 97% of the Galician population. The data collection was done mainly by computer-assisted telephone interview (90%); however, 10% of the interviews (the percentage of people in the register without a landline or a mobile phone) were conducted face-to-face at the individuals' homes. The initial selected sample (n = 6492) was representative according to sex and age groups: 16-24, 25-44, and 45-74. The participants were asked about smoking history, tobacco labours consumption (different types of tobacco consumed by the population, i.e. cigars, cigarettes, pipes and so on), dependence, relapse or cessation motivation. They were also asked if they were current (daily or occasional), former or never smokers. Demographic and socio-cultural information were also ascertained. Daily smokers were defined as individuals who smoke cigarettes regularly, i.e., at least one cigarette per day. Individuals who were exclusively cigar or pipe smokers were excluded from this analysis. The FTND and the HSI were administered only to the daily smokers. The FTND has 6 items with an overall score ranging between 0-10. The HSI has two items with an overall score ranging between 0-6. As in other studies, high dependence was defined as a FTND score ≥ 6 [3–11] and a HSI score ≥ 4 [5, 8, 12].
FTND was established as gold standard and the following statistics, summarizing the diagnostic accuracy of the HSI, were obtained, and also stratified by sex: sensitivity, specificity, accuracy and positive and negative predictive values. The concordance between HSI and FTND was evaluated using Cohen's kappa. The data were analyzed with Stata v9.2. 95% CIs were computed.
Ethical approval from Galician ethics committee was not required because this was a voluntary and anonymous research study with confidentially fully guaranteed. Written informed consent was not applicable in this case because the study was conducted mainly by telephone and agreement to participate implies consent.
The daily smokers included in this study, with a response rate of 85%, were 1655 (941 males and 714 females). Their mean age was 36.7 years (CI 95%: 36.3-37.1), 63% were employed, 52% had intermediate or superior degree studies and 61% were married. Their mean tobacco consumption was 15.4 (CI 95%: 14.8-15.9) cigarettes per day. The age of first experience with tobacco was 16.2 years (CI 95%: 15.9-16.4) and the onset age of regularly smoking was 18.7 (CI 95%: 18.4-18.9). More than half of the smokers had not attempted smoking cessation during the last year [56.3% (CI 95%: 52.9-59.6)].
Dependence measured with FTND and HSI tests in the 1655 daily smokers: concordance between them, and diagnostic accuracy statistics of HSI.
0.75 (p < 0.0001)
0.60 (p < 0.0001)
0.70 (p < 0.0001)
Sensitivity, CI (95%)
Specificity, CI (95%)
Accuracy, CI (95%)
+PV, CI (95%)
-PV, CI (95%)
Diagnostic tests are also shown in this table. The results verified that HSI has good specificity and good sensitivity in males; however, for females the test misses nearly 40% of highly dependent female smokers (sensitivity: 62.3%).
The proportion of persons correctly classified by dependence level using the HSI test, accuracy, is high (94%). The negative predictive value, low dependence, of the HSI is higher (97%) than the positive predictive value, high dependence (71.6%).
The HSI and FTND identified almost the same percentage of daily smokers with high dependence. Though the specificity, accuracy and concordance between the two instruments were high in males and females, the HSI sensitivity for the latter was relatively low. For planning purposes it is preferable to use tests with high sensitivity , and therefore this result supports the use of the FTND instead of HSI. Nevertheless it should be acknowledged that using FTND as the gold standard has some limitations. FTND does not cover different aspects of dependence such as the difficulties in controlling tobacco consumption or unsuccessful efforts to quit.
Prior studies comparing FTND and HSI as measures of high nicotine dependence.
Age range: 18-64
Face to face
1,462 smokers (5 samples from the US and Spain)
Face to face
Age range: 15 and over
Face to face
One explanation for the differences found in this study for men and for women is that, in general, women tend to smoke fewer cigarettes per day. In our sample 94% smoke less than 20 cigarettes per day and 56% less than 11. For males these figures are 83% and 34% respectively. Differences also appear for time to first cigarette but are of a less magnitude. The differences for both questions are statistically significant but it appears that cigarettes per day have a higher influence than time to first cigarette.
Our data supports other findings supporting the HSI as a valuable test for the assessment of nicotine dependence [1, 5, 6, 8, 12, 15, 16] and busy clinicians can use this test as an accurate screener of high nicotine dependence.
Some identified limitations of this study were: (a) data were gathered only by self-reporting and were not verified by other measures ; (b) originally both tests were developed using face to face written forms but we utilized mainly telephone calls; (c) the study did not take into account the use of other tobacco products such as pipes or cigars; (d) the self-reported data may be limited by misclassification bias or some other bias that may have influenced the dependence values, such as the digit preference of smokers reporting consumption in multiples of 10 cigarettes per day ; and (e) limitations related to the fact that analysis with Kappa values is influenced by prevalence. Among the study strengths was the use of a general population framework, a large sample randomly selected and a high participation rate.
When planning and managing health resources directed to prevent tobacco consumption it is important to know the nicotine dependence of the objective population. Although concordances between both tests were relatively high, FTND test should be considered the best option for screening of nicotine dependence since it has a better performance on both sexes. If resources are scarce and the sample is high, HSI can be an option since it is low-time consuming but keeping in mind its limitations when measuring women dependence.
Thereby, efforts to develop a short self-report tool in order to assess nicotine dependence for epidemiological studies should continue.
The sensitivity values in females cause us to choose the FTND test as the preferred dependence screening instrument for health policy design.
Thereby, efforts to develop a short self-report measure of nicotine dependence for epidemiological studies should continue.
- Heatherton T, Kozlowski L, Frecker R, Fagerström K: The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. British J Adict. 1991, 86: 1119-27. 10.1111/j.1360-0443.1991.tb01879.x.View ArticleGoogle Scholar
- Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989, 84 (7): 791-9. 10.1111/j.1360-0443.1989.tb03059.x.View ArticlePubMedGoogle Scholar
- Fagerstrom KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, et al: Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control. 1996, 5 (1): 52-6. 10.1136/tc.5.1.52.View ArticlePubMedPubMed CentralGoogle Scholar
- Gallus S, La Vecchia C: A population-based estimate of tobacco dependence. Eur J Public Health. 2004, 14 (1): 93-4. 10.1093/eurpub/14.1.93.View ArticlePubMedGoogle Scholar
- Diaz FJ, Jane M, Salto E, Pardell H, Salleras L, Pinet C, et al: A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys. Aust N Z J Psychiatry. 2005, 39 (3): 161-8.View ArticlePubMedGoogle Scholar
- Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T: Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI: Drug Alcohol Depend. 1994, 34 (3): 211-6.Google Scholar
- Moolchan ET, Radzius A, Epstein DH, Uhl G, Gorelick DA, Cadet JL, et al: The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers?. Addict Behav. 2002, 27 (1): 101-13. 10.1016/S0306-4603(00)00171-4.View ArticlePubMedGoogle Scholar
- de Leon J, Diaz FJ, Becona E, Gurpegui M, Jurado D, Gonzalez-Pinto A: Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav. 2003, 28 (8): 1481-6. 10.1016/S0306-4603(02)00264-2.View ArticlePubMedGoogle Scholar
- Fagerstrom KO, Heatherton TF, Kozlowski LT: Nicotine addiction and its assessment. Ear Nose Throat J. 1990, 69 (11): 763-5.PubMedGoogle Scholar
- de Leon J, Becona E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ: The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry. 2002, 63 (9): 812-6.View ArticlePubMedGoogle Scholar
- John U, Meyer C, Rumpf HJ, Hapke U: Smoking, nicotine dependence and psychiatric comorbidity--a population-based study including smoking cessation after three years. Drug Alcohol Depend. 2004, 76 (3): 287-95. 10.1016/j.drugalcdep.2004.06.004.View ArticlePubMedGoogle Scholar
- Chabrol H, Niezborala M, Chastan E, de Leon J: Comparison of the Heavy Smoking Index and of the Fagerstrom Test for Nicotine Dependence in a sample of 749 cigarette smokers. Addict Behav. 2005, 30 (7): 1474-7. 10.1016/j.addbeh.2005.02.001.View ArticlePubMedGoogle Scholar
- Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33 (1): 159-74. 10.2307/2529310.View ArticlePubMedGoogle Scholar
- Viladrich M, Doval E: Medición: Fiabilidad y Validez. 2007, Bellaterra.: Laboratori d'Estadistica Aplicada i Modelització (UAB)Google Scholar
- de l'Homme G, Bacque MF, Housset B, Lebeau B: [Tobacco dependence: a short evaluation questionnaire]. Presse Med. 1992, 21 (13): 606-8.PubMedGoogle Scholar
- John U, Meyer C, Schumann A, Hapke U, Rumpf HJ, Adam C, et al: A short form of the Fagerstrom Test for Nicotine Dependence and the Heaviness of Smoking Index in two adult population samples. Addict Behav. 2004, 29 (6): 1207-12. 10.1016/j.addbeh.2004.03.019.View ArticlePubMedGoogle Scholar
- Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S: The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994, 84 (7): 1086-93. 10.2105/AJPH.84.7.1086.View ArticlePubMedPubMed CentralGoogle Scholar
- Klesges RC, Debon M, Ray JW: Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey. J Clin Epidemiol. 1995, 48 (10): 1225-33. 10.1016/0895-4356(95)00020-5.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/9/493/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.